Florida Senate - 2017 (NP) SR 1840
By Senator Flores
39-03508-17 20171840__
1 Senate Resolution
2 A resolution recognizing May 2017 as “Cystic Fibrosis
3 Awareness Month” in Florida.
4
5 WHEREAS, cystic fibrosis is a genetic disease that affects
6 more than 1,400 children and adults in Florida, more than 30,000
7 children and adults in the United States, and nearly 70,000
8 children and adults worldwide, and
9 WHEREAS, cystic fibrosis is triggered by a defective gene
10 that causes the body to produce an abnormally thick, sticky
11 mucus that clogs the lungs, and these secretions produce life
12 threatening lung infections and obstruct the pancreas,
13 preventing digestive enzymes from reaching the intestines to
14 help break down and absorb food, and
15 WHEREAS, more than 10 million Americans are symptomless
16 carriers of the cystic fibrosis gene, and the disease occurs in
17 approximately one of every 3,500 live births in the United
18 States, and
19 WHEREAS, the median age of survival for a person with
20 cystic fibrosis is 41 years, and
21 WHEREAS, the number of adults with cystic fibrosis has
22 steadily grown, and approximately 900 new cases of the disease
23 are diagnosed each year, and
24 WHEREAS, 51 percent of persons with cystic fibrosis are 18
25 years of age and older, and people with cystic fibrosis have a
26 variety of symptoms attributed to the more than 1,800 mutations
27 of the cystic fibrosis gene, and
28 WHEREAS, infant blood screening to detect genetic defects
29 is the most reliable and least costly method to identify persons
30 likely to have the disease, and
31 WHEREAS, early diagnosis of cystic fibrosis permits early
32 treatment and enhances quality of life and longevity, and
33 WHEREAS, clearing mucus from the lungs is an important part
34 of the daily cystic fibrosis treatment regimen, and other types
35 of treatments include inhaled antibiotics and pancreatic
36 enzymes, and
37 WHEREAS, there are 20 world-class treatment centers in
38 Florida that specialize in the diagnosis and care of persons
39 with cystic fibrosis, and
40 WHEREAS, a critical component of treating patients with
41 cystic fibrosis includes access to innovative treatments that
42 can play a crucial role in their lives, and
43 WHEREAS, improving the length and quality of life for
44 people with cystic fibrosis starts with awareness, NOW,
45 THEREFORE,
46
47 Be It Resolved by the Senate of the State of Florida:
48
49 That May 2017 is recognized as “Cystic Fibrosis Awareness
50 Month” in Florida.